Analyst Research

Report Title Price
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aperam gives Q3 FY 2014 outlook in line with analysts' estimates

Thursday, 31 Jul 2014 11:45am EDT 

Aperam SA:Sees Q3 FY 2014 EBITDA to be lower compared to EBITDA in Q2 FY 2014.Q2 FY 2014 EBITDA $164 mln.Q3 FY 2014 EBITDA $95 mln - Thomson Reuters I/B/E/S. 

Company Quote

-0.35 -1.43%
23 Jan 2015